A Functional Tissue-Engineered Synovium Model to Study Osteoarthritis Progression and Treatment

Area of Science:

• Biomedical Engineering
• Orthopedics
• Tissue Engineering

Background:

• The synovium, a joint lining, regulates synovial fluid composition and is implicated in osteoarthritis pathogenesis.
• Synovial changes often precede cartilage damage, highlighting the need to study synovial function.

Purpose of the Study:

• To develop and validate a novel in vitro tissue-engineered synovium model.
• To investigate the structure-function relationship of the synovium using quantitative solute transport.
• To assess the impact of interleukin-1 and dexamethasone on synovial transport properties.

Main Methods:

• Development of a tissue-engineered synovium model.
• Validation of the model against native synovium explants.
• Quantitative measurement of solute transport across the engineered synovium.
• Evaluation under pro-inflammatory (interleukin-1) and corticosteroid (dexamethasone) conditions.

Main Results:

• The engineered synovium model accurately recapitulates native synovium transport properties.
• Interleukin-1 significantly altered synovial transport, indicating inflammatory effects.
• Dexamethasone demonstrated modulatory effects on synovial transport.

Conclusions:

• The validated in vitro model provides a powerful tool for studying synovium function.
• Understanding synovium transport dynamics is crucial for developing osteoarthritis therapies.
• This model can facilitate the development of strategies to restore joint health.